Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CysLT2 Receptor Inhibitors

CysLT2 receptor inhibitors constitute a chemical class of compounds that and reversibly target the CysLT2 receptor, which is a G-protein-coupled receptor belonging to the leukotriene receptor family. This receptor plays a crucial role in mediating the effects of cysteinyl leukotrienes, which are inflammatory mediators formed during the metabolism of arachidonic acid. These inhibitors are specifically engineered to interact with the CysLT2 receptor, aiming to disrupt its signaling and modulate the cellular responses triggered by cysteinyl leukotrienes. The chemical structure of CysLT2 receptor inhibitors enables them to bind to specific regions or binding sites on the receptor, potentially blocking its activation by leukotrienes. Researchers employ CysLT2 receptor inhibitors in biochemical and cellular studies to elucidate the functions of the receptor in inflammation and its potential implications in various disease processes. The design and development of these inhibitors rely on a comprehensive understanding of the CysLT2 receptor's structural features and its involvement in leukotriene-mediated signaling, providing valuable tools for advancing research in the field of inflammatory pathways and cellular responses.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAY-u 9773

154978-38-8sc-203835
50 µg
$155.00
(0)

BAYu9773 is a selective CysLT2 receptor antagonist that has been studied for its effects on leukotriene-mediated inflammation.